期刊文献+

中国白质消融性白质脑病患儿EIF2B1-5基因型特点 被引量:5

Genotypic features of EIF2B1-5 in Chinese patients with vanishing white matter disease
原文传递
导出
摘要 目的对临床确诊为白质消融性白质脑病(VWM)的33例患儿进行遗传学分析,探讨中国VWM患儿基因型特点并为中国VWM患儿提供基因诊断策略。方法以2006年9月至2013年7月临床诊断为VWM的33例患儿为研究对象,对其EIF281—5基因外显子及外显子与内含子交界区进行基因测序及拷贝数异常检测;采用等位基因特异性聚合酶链反应(PCR)方法验证患者中的常见突变E1F283c.1037T〉C(P.Ile346Thr)是否为创始者突变。结果1.本组33例患儿基因突变阳性29例,阳性率与国外报道一致(88%比90%)。2.共发现EIF281-5突变32种,其中23种为国外未报道的新突变,以错义突变为主。3.患者突变谱与国外报道不同:29例基因突变阳性患儿中EIF285突变占38%(11/29例),EIF283突变占31%(9/29例),EIF284突变占17%(5/29例),EIF282突变占10%(3/29例),EIF281突变占3%(1/29例),其中EIF283突变患者所占比率明显高于国外报道(4%)。4.等位基因特异性PCR显示包含EIF283基因c.1037T〉C突变位点的单倍体上下游各2200bp范围内有相同的单核苷酸多态性(SNPs)。结论EIF283突变的患儿在中国VWM患儿中所占比例明显高于白种人群(31%比4%),提示中国患儿有自己独特的突变构成谱。EIF283的c.1037T〉C为中国患者的创始者突变。 Objective To analyze the genotype of Chinese patients clinically diagnosed with vanishing white matter disease (VWM) clinically and to provide the genetic diagnostic strategy for children with VWM. Methods Thirty-three Chinese patients were sequenced in the coding regions and splice sites of E1F2B1-5. Copy number variations (CNVs) were tested in mutation negative patients. Among the 9 patients who carried mutations in eIF2Bγ,7 cases (78% ,7/9 cases) harbored at least one copy of the c. 1037T 〉 C( p. Ile346Thr). The nature of founder mutation was suspected and determined by allele-specific PCR. Results 1. Mutations in EIF2B1-5 were identified in 29 cases (88% ,29/33 cases) ,which was compared with the data from Caucasian patients (88% vs 90% ). 2. Thirty-two different mutations were identified, consisting of 23 novel and 9 previously reported mutations. 3. The constituent ratio of patients was different from caucasian patients. In 29 mutation-positive children, E1F2B5 accounted for 38% ( 11/29 cases) ,EIF2B3 31% (9/29 cases) ,EIF2B4 17% (5/29 cases) ,EIF2B2 10% (3/29 cases) ,and EIF2BI accounted for 3% (1/29 cases). Patients with E1F2B3 mutations were more common in Chinese patients. 4. The SNPs on the mutant allele amplified by allele specific PCR were compared among all the patients who harbored the EIF2B3-c. 1037T 〉 C mutation. Within 2 200 bp up and down stream surrounding the c. 1037, all the mutant alleles shared the same SNPs. Conclusions The percentage of Chinese patients with EIF2B3 mutation is much higher than that of Caucasian population (31% vs 4% ), indicating that Chinese children with VWM have unique spectrum of mutations. EIF2B3-c. 1037T 〉 C is the founder mutations in Chinese patients.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2014年第1期52-56,共5页 Chinese Journal of Applied Clinical Pediatrics
基金 基金项目:国家自然科学基金(81171065)
关键词 白质消融性白质脑病 基因型 创始者突变 Vanishing white matter disease Genotype Founder mutation
  • 相关文献

参考文献15

  • 1Bugiani M,Boor I,Powers JM. Leukoencephalopathy with vanishing white matter:a review[J].Journal of Neuropathology and Experimental Neurology,2010,(10):987-996.
  • 2Valálik I,van der Knaap MS,Scheper GC. Long-term tremor control with bilateral Vim-DBS in vanishing white matter disease[J].Parkinsonism & Related Disorders,2012,(09):1048-1050.
  • 3代丽芳,吴晔,王静敏,杜丽,冷雪荣,潘艳霞,朱赛楠,姜玉武.中国早期儿童型白质消融性白质脑病患儿17例自然病程随访及其基因型-表型分析[J].实用儿科临床杂志,2011,26(10):773-777. 被引量:6
  • 4Vander KM,Pronk JC,ScheperGC. Vanishing white matter disease[J].Lancet Neuro1,2006,(05):413-423.
  • 5Labauge P,Horzinski L,Ayrignac X. Natural history of adult-onset eIF2B-related disorders:a multi-centric survey of 16 cases[J].BRAIN,2009,(Pt 8):2161-2169.
  • 6Ghezzi L,Scarpini E,Rango M. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation[J].NEUROLOGY,2012,(20):2077-2078.
  • 7Matsukawa T,Wang X,Liu R. Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2,EIF2B3,and EIF2B5[J].NEUROGENETICS,2011,(03):259-261.
  • 8Agorastos A,Huber CG. Vanishing white-matter disease:a case of severe adult onset with prolonged course under anticonvulsivetherapy[J].Journal of Neuropsychiatry and Clinical Neurosciences,2012,(04):E24-E25.
  • 9Pronk JC,van KB,Scheper GC. Vanishing white matter disease:a review with focus on its genetics[J].Mental Retardation and Developmental Disabilities Research Reviews,2006,(02):123-128.
  • 10Maletkovic J,Schiffmann R,Gorospe JR. Genetic and clinical heterogeneity in eIF2B-related disorder[J].Child Neurology,2008,(02):205-215.

二级参考文献18

  • 1Van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease [ J ]. Lancet Neurol,2006,5 (5) :413 - 423.
  • 2Wu Y, Pan Y, Du L,et al. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter[ J]. J Hum C, enet ,2009 ,54 (2) :74 -77.
  • 3Labauge P, Horzinski L, Ayrignac X,et al. Natural history of adult -on- set elF2B - related disorders : A multi - eentric survey of 16 eases [ J ].Brain,2009,132(Pt 8) :2161 -2169.
  • 4Fogli A, Schiffmann R, Bertini E, et al. The effect of genotype on the natural history of elF2B - related leukodystrephies [ J]. Neurology, 2004,62( Pt 9) :1509 - 1517.
  • 5Springer S, Erlewein R, Naegele T,et al. Alexander disease - classification revisited and isolation of a neonatal form [ J ]. Neuropediatrics, 2000, 31(2) :86 -92.
  • 6Bembeeva RTs, Serkov SV, Nankina IA,et al. Megalencephalie leukoencephalopathy with subcortical eysts ( van der Knaap disease) [ J ]. Zh Nevrol Psikhiatr Im S S Korsakova,2008,108( 11 ) :4 -9.
  • 7Cappa M, Bizzarri C, Vollono C, et al. Adrenoleukodystrophy [ J ]. Endocr Dev,2011,20 : 149 - 160.
  • 8Kehrer C, Blumenstock G, Raabe C, et al. Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy[ J ]. Dev Med Child Neurol, 2011,53 (2) : 156 - 160.
  • 9Korn -Lubetzki IK,Dor- Wollman TD, Softer D,et al,Early peripheral nervous system manifestations of infantile krabbe disease [ J ]. Pediatr Neurol,2003,28(2) :115 - 118.
  • 10Morse LE, Rosman NP. Myoclonic seizures in Krabbe disease: A unique presentation in late - onset type [ J ]. Pediatr Neurol, 2006,35 (2) :154 -157.

共引文献5

同被引文献25

  • 1吴晔,姜玉武,秦炯,肖江喜,王静敏,杨艳玲,张月华,常杏芝,林庆,吴希如.白质消融性白质脑病临床分析[J].中华儿科杂志,2007,45(2):115-120. 被引量:12
  • 2van der KnaapMS,PronkJC,ScheperGC.Vanishing white matter disease[J].Lancet Neurol,2006,5(5):413-423.
  • 3van der VoornJP,van KollenburgB,BertrandG,et al.The unfolded protein response in vanishing white matter disease[J].J Neuropathol Exp Neurol,2005,64(9):770-775.
  • 4van KollenburgB,van DijkJ,GarbernJ,et al.Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease[J].J Neuropathol Exp Neurol,2006,65(7):707-715.
  • 5BugianiM,PostmaN,PolderE,et al.Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease[J].Brain,2013,136(Pt 1):209-222.
  • 6LinY,PangX,HuangG,et al.Impaired eukaryotic translation initiation factor 2B activity specifically in oligodendrocytes reproduces the patho-logy of vanishing white matter disease in mice[J].J Neurosci,2014,34(36):12182-12191.
  • 7MiyamotoY,ToriiT,EguchiT,et al.Hypomyelinating leukodystrophy-associated missense mutant of FAM126A/hyccin/DRCTNNB1A aggregates in the endoplasmic reticulum[J].J Clin Neurosci,2014,21(6):1033-1039.
  • 8van HarenK,van der VoornJP,PetersonDR,et al.The life and death of oligodendrocytes in vanishing white matter disease[J].J Neuropathol Exp Neurol,2004,63(6):618-630.
  • 9HussienY,CavenerDR,PopkoB.Genetic inactivation of PERK signaling in mouse oligodendrocytes:normal developmental myelination with increased susceptibility to inflammatory demyelination[J].Glia,2014,62(5):680-691.
  • 10JenningsMD,PavittGD.A new function and complexity for protein translation initiation factor eIF2B[J].Cell Cycle,2014,13(17):2660-2665.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部